Patent details

EP2327416 Title: Pharmacological vitreolysis using truncated plasmin

Basic Information

Publication number:
EP2327416
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP111524146
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmacological vitreolysis using truncated plasmin
French Title of Invention:
Vitréolyse pharmacologique en utilisant une plasmine raccourci
German Title of Invention:
Pharmakologische Vitreolyse unter Verwendung eines verkürzten Plamins
SPC Number:

Dates

Filing date:
05/12/2003
Grant date:
01/05/2019
EP Publication Date:
01/06/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/05/2019
EP B1 Publication Date:
01/05/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
05/12/2021
Expiration date:
05/12/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/04/2019
 
 

Name:
Oxurion NV
Address:
Gaston Geenslaan 1, 3001 Leuven, Belgium (BE)

Agent

Name:
NV GEVERS PATENTS
From:
13/05/2019
Address:
HOLIDAYSTRAAT 5, 1821, DIEGEM - BRUXELLES, Belgium (BE)
To:

Inventor

1

Name:
De Smet, Marc
Address:
Netherlands (NL)

2

Name:
Pakola, Steve
Address:
United States (US)

Priority

Priority Number:
0228409
Priority Date:
06/12/2002
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 38/48; A61P 41/00;

Publication

European Patent Bulletin

Issue number:
201918
Publication date:
01/05/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
29/12/2020
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
IPAN GMBH
Filing date Document type Number of pages
13/05/2019 Power Of Attorney 1
17/05/2019 Outgoing Correspondence 1